Personalized treatment of early-stage non-small-cell lung cancer: the challenging role of EGFR inhibitors.
about
Programmed cell death protein-1/programmed cell death ligand-1 pathway inhibition and predictive biomarkers: understanding transforming growth factor-beta roleExpressions of CD8+TILs, PD-L1 and Foxp3+TILs in stage I NSCLC guiding adjuvant chemotherapy decisions.5'-nucleotidase cN-II emerges as a new predictive biomarker of response to gemcitabine/platinum combination chemotherapy in non-small cell lung cancer.Liquid biopsy for lung cancer early detection.
P2860
Personalized treatment of early-stage non-small-cell lung cancer: the challenging role of EGFR inhibitors.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Personalized treatment of earl ...... nging role of EGFR inhibitors.
@en
type
label
Personalized treatment of earl ...... nging role of EGFR inhibitors.
@en
prefLabel
Personalized treatment of earl ...... nging role of EGFR inhibitors.
@en
P2093
P2860
P356
P1433
P1476
Personalized treatment of earl ...... nging role of EGFR inhibitors.
@en
P2093
Giuseppe Altavilla
Mariacarmela Santarpia
Vincenzo Pitini
P2860
P304
P356
10.2217/FON.14.320
P407
P577
2015-01-01T00:00:00Z